Jean Donadieu
Overview
Explore the profile of Jean Donadieu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
195
Citations
6159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vicario R, Fragkogianni S, Pokrovskii M, Meyer C, Lopez-Rodrigo E, Hu Y, et al.
Neuron
. 2025 Mar;
PMID: 40081365
Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD) are clonal myeloid disorders associated with mitogen-activated protein (MAP)-kinase-activating mutations and an increased risk of neurodegeneration. We found microglial mutant clones in...
2.
Cuntz F, Donadieu J, Holzhauer S
J Pediatr Hematol Oncol
. 2025 Mar;
PMID: 40042809
Background: Above 50% of LCH cases show BRAF-mutations, which can be targeted by dabrafenib in refractory disease. Observations: Here, we report on a patient with neonatal multisystem, BRAF-mutated LCH refractory...
3.
Hadjadj J, Wolfers A, Borisov O, Hazard D, Leahy R, Jeanpierre M, et al.
Lancet Rheumatol
. 2025 Mar;
PMID: 40024253
Background: Suppressor of cytokine signalling 1 (SOCS1) insufficiency is an inborn error of immunity affecting the negative regulation of cytokine and growth factor signalling. We aimed to enhance the understanding...
4.
Bigenwald Dr C, Roos-Weil D, Pages A, Helias-Rodzewicz Z, Copie-Bergman C, Nashvi M, et al.
Blood Adv
. 2025 Feb;
PMID: 40009752
Malignant histiocytoses (MH) are rare and poorly understood cancers, with no established therapeutic guidelines. We conducted a national retrospective study of MH diagnosed in France between 2000 and 2023. All...
5.
Trognon A, Stortini N, Duman C, Koide N, Skupinska E, Altakroury H, et al.
Front Psychol
. 2025 Feb;
15:1459549.
PMID: 39911189
Background: Shwachman-Diamond Syndrome (SDS) is a rare genetic disorder with documented cognitive and behavioral challenges. However, its socio-pragmatic dynamics remain underexplored, particularly in cooperative interactions where social norms and economic...
6.
Fekadu-Siebald J, Salzmann-Manrique E, Heusel J, Willasch A, Hauck F, Gonzalez-Granado L, et al.
Blood Adv
. 2025 Jan;
PMID: 39775668
JAGN1 (Jagunal-homolog1) is a ER-resident transmembrane protein which is part of the early secretory pathway and granulocyte colony-stimulating factor receptor mediated signaling. Autosomal recessively inherited variants in the JAGN1 gene...
7.
Thalhammer J, Jeziorski E, Marec-Berard P, Barkaoui M, Barkaoui M, Pagnier A, et al.
Blood
. 2024 Nov;
145(10):1061-1073.
PMID: 39486044
Hematological involvement (HI) is one of the life-threatening risk organs (ROs) in Langerhans cell histiocytosis (LCH). Lahey criteria have defined HI since 1975 as hemoglobin <10 g/dL, platelets <100 ×...
8.
Ozkaya N, Melloul Benizri S, Venkataraman G, Karai L, Fraitag S, Razanamahery J, et al.
Blood Adv
. 2024 Oct;
8(22):5796-5805.
PMID: 39361706
Indeterminate dendritic cell histiocytosis (IDCH) is a rare and poorly understood entity characterized by accumulation of CD1a+/S100+ histiocytes (as Langerhans cell histiocytosis [LCH]) but with reduced-absent expression of Langerin/CD207. We...
9.
Emile J, Pluchart C, Azoulay L, Quere B, Venton G, Filhon B, et al.
J Hematop
. 2024 Aug;
17(4):289-293.
PMID: 39212850
No abstract available.
10.
Sicre de Fontbrune F, Chevillon F, Fahd M, Desseaux K, Poire X, Forcade E, et al.
Br J Haematol
. 2024 Aug;
PMID: 39159950
Modalities and timing of haematopoietic stem cell transplant (HSCT) in patients with GATA2 deficiency are still subject to debate. On June 2022, 67 patients (median age 20.6 years) underwent a...